CCL28 and HIV infectious disease: Notably, the beneficial immunomodulatory effects of CCL28 is not likely limited to HIV infection as this chemokine was recently shown to be effective in eliciting long-lived antibody responses that neutralized influenza A/PR8/34 and protected mice from morbidity and mortality associated with a lethal intranasal viral challenge [22].